Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07593092 |
| Title | Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors |
| Recruitment | Not yet recruiting |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Xencor, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Xencor Investigative Site | Detroit | Michigan | 48201 | United States | Details | |
| Xencor Investigative Site | Omaha | Nebraska | 68198 | United States | Details | |
| Xencor Investigative Site | Lake Success | New York | 11042 | United States | Details | |
| Xencor Investigative Site | New York | New York | 10029 | United States | Details | |
| Xencor Investigative Site | The Bronx | New York | 10461 | United States | Details | |
| Xencor Investigative Site | Columbus | Ohio | 43210 | United States | Details | |
| Xencor Investigative Site | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| Xencor Investigative Site | Fort Worth | Texas | 76104 | United States | Details | |
| Xencor Investigative Site | Houston | Texas | 77030 | United States | Details |